GLP1R and atherosclerosis: To understand the relevance of these findings in human atherosclerosis, a library of human atherosclerotic plaques with varying stages of atherosclerosis was screened for their immunoreactivity to extensively validated 3F52 anti-GLP-1R monoclonal antibody 15.